Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
for Hematologic Malignancies
Drug: Nemtabrutinib
11 locations incl. Springdale
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT04728893·Phase 2·Recruiting